IMPORTANT LIPOCINE, INC. SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Reminds Investors That a Class Action Lawsuit Has Been Commenced on Behalf of Shareholders of Lipocine, Inc.
Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf of purchasers of Lipocine, Inc. (“Lipocine” or the “Company”) (LPCN) between June 30, 2015 and June 28, 2016, inclusive (the “Class Period”). Shareholders who have purchased …